News
Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Perspective Therapeutics (CATX – Research Report) today and set a price target of $6.00. The company’s shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback